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pen access Abstract Objective: To assess the effect of intrathecal Bupivacain–Lidocaine combination at dif-
ferent doses of Lidocaine (6 and 12 mg) on the onset and recovery of anesthesia.
Methods: Ninety patients who were scheduled for elective lower abdominal surgery were randomly
allocated into three equal groups: Group I; 30 patients received 1.5 mL hyperbaric 0.5%
Bupivacaine + 0.6 mL saline. Group II; 30 patients received 1.5 mL hyperbaric 0.5%
Bupivacaine + 0.6 mL 1% Lidocaine [6 mg] mixed. Group III; 30 patients received 1.5 mL hyper-
baric 0.5% Bupivacaine + 0.6 mL 2% Lidocaine [12 mg]. Peak sensory block level, time to peak
sensory block, times to two-segment, S2 regressions from peak sensory block, motor blocks at peak
sensory block and total motor block duration, post anesthesia care unit stay time and analgesia time
were measured.
Results: The median height of peak sensory block in Group III was higher than in Groups I or II.
Times to two-segment and S2 regressions from peak sensory block, motor block duration and
PACU time were signiﬁcantly reduced in Group II compared to Group I and III. No patient
required general anesthesia. No patients experienced postdural puncture headache or TNS.
Conclusions: Lidocaine 1% (6 mg) mixed to spinal 1.5 mL hyperbaric 0.5% Bupivacaine (7.5 mg)
can shorten the duration of Bupivacaine spinal anesthesia, provide more rapid recovery from the5257416; fax: +20 403349359.
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Bupivacaine is proposed as an alternative to Lidocaine because
of the concerns about transient neurologic symptoms (TNS).
Although TNS was not associated with either Lidocaine con-
centration or dose, its incidence has never been examined with
very small doses of spinal Lidocaine.1 However, Bupivacaine
may have too long duration to be useful in the ambulatory set-
ting or for surgeries of short duration. Problems of delayed
discharge after ambulatory surgery using Bupivacaine and
the high incidence of TNS associated with the use of Lidocaine
have resulted in controversy concerning the continued use of
spinal Lidocaine or Bupivacine.2 Recent animal data suggested
that intrathecal Lidocaine added to Bupivacaine may reduce
the duration of Bupivacaine spinal anesthesia by increasing
the clearance of intrathecal Bupivacaine.3
2. Aim of the work
1. Assessing the effect of intrathecal Bupivacaine–Lidocaine
combination at different doses of Lidocaine (6 and
12 mg) on the onset and recovery of anesthesia; times to
retain motor ability and post-operative analgesia required.
2. Study the effect of this combination on the hemodynamic
side effect and neurological complications especially tran-
sient neurological symptoms (TNS).
2.1. Study design
Prospective, randomized, double blind study.
2.2. Settings
It was conducted at Ain Shams University Hospitals, Cairo,
Egypt (from August 2008 to February 2011).3. Patients and methods
Ninety adults patients who were scheduled for elective lower
abdominal surgery (inguinal hernia), anal surgery (e.g. pre-
anal ﬁstula, piles) and knee arthroscopy under spinal anesthe-
sia after approval of the research ethics committee of Ain
shams University and obtaining an informed consent from
each patient were prepared for spinal anesthetic blockade. Pa-
tients included were adult aged ranged from 18 to 60 of both
sex ASA I (American Society of Anesthesiologists normal
healthy patient), ASA II (American Society of Anesthesiolo-
gists patient with mild systemic disease with no functional lim-
itations; has a well-controlled disease of one body system),
having an irritable airway (bronchial asthma or allergic bron-
chitis) or abnormalities which make endotracheal intubationvery difﬁcult (e.g. micrognathia) and borderline hypertensive
patients where administration of general anesthesia or endo-
tracheal intubation can further elevate the blood pressure. Pa-
tients excluded were those with preexisting neurological deﬁcit,
coagulation disorders, local infection at the site of proposed
lumbar puncture or bacteremia, hepatic or renal dysfunction,
history of allergy to amide local anesthetics, disorders of the
spine and those who refused to receive spinal anesthesia.
All patients selected underwent pre-operative assessment
for evaluation of the patient’s medical status. No premedica-
tion was given and on arrival to the operating room continu-
ous monitoring with electrocardiography (ECG), non
invasive blood pressure and pulse oximetry were started. A
suitable peripheral vein was cannulated and Ringer’s solution
10–20 mL/kg preload was given to all patients over 15 min
immediately before spinal anesthesia. The patients were placed
in the sitting position for lumbar puncture which was per-
formed using midline approach at L4–L5 interspaces under
aseptic conditions using a 25 gauge Quincke spinal needle.4
After obtaining a free ﬂow of cerebrospinal ﬂuid, the appropri-
ate local anesthetic solution was injected intrathecally.
Patients were randomly allocated into three equal groups
(30 patients each) according to the type of the drug injected:
Group I (control group): 30 patients received 1.5 mL hyper-
baric 0.5% Bupivacaine [7.5 mg in 8% dextrose] + 0.6 ml sal-
ine mixed together in one syringe. Group II: 30 patients
received 1.5 mL hyperbaric 0.5% Bupivacaine + 0.6 mL 1%
Lidocaine [6 mg] mixed together in one syringe. Group III:
30 patients received 1.5 mL hyperbaric 0.5% Bupivacaine +
0.6 mL 2% Lidocaine [12 mg] mixed together in one syringe.
The dose (6 mg) had been calculated as 1% Lidocaine means
that each 100 mL contain 1 gm so, {0.6 mL · 1/100} = 0.006
gm= 6 mg.
Then the patient was placed in the supine position remain-
ing in the ﬂat position with elevation of the shoulders with a
pillow. Oxygen mask was used (4 L/min).The level of sensory
block was assessed by pin prick test every 30 s for 5 min then
every 5 min for 20 min.5 The patient’s position was adjusted
so that the sensory level was ﬁxed at T10 dermatom. Intrave-
nous Ringer’s solution was given at rate of 8 mL/kg/h. If the
arterial blood pressure had decreased by more than 20% below
pre-anesthetic value, the patient was given intermittent doses
of ephedrine (5–10 mg I.V.). If the heart rate had decreased be-
low 60 beats/min I.V. atropine was given at a dose of 0.01–
0.02 mg/kg. All facilities for using general anesthesia were
available all the time. All patients were transferred to the post
anesthesia care unit (PACU) following the surgery. The dis-
charge criteria from the PACU included stable vital signs
(no more or less than 20% of the initial MAP (mean arterial
blood pressure) and HR (heart rate) values, oriented mental
state, no active bleeding, no severe pain and S2 regression of
sensory block. The motor block degree and duration (the times
to full ﬂexion of knees and feet) were also recorded using
Modiﬁed Bromage Scale. The duration of stay in the PACU
(PACU time) was determined for each patient. After the
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Figure 1 The difference between all studied groups as regards
mean values of times to Rescue analgesia.
Effect of intrathecal Bupivacaine–Lidocaine combination 63surgery, an anesthesiologist visited the patients to assess com-
plications such as postdural puncture headache or TNS
(deﬁned by pain or dysesthesia in the buttocks or legs after
recovery from uncomplicated spinal anesthesia).
The time to the ﬁrst postoperative analgesic dose (analgesia
time) was recorded, postoperative analgesia consisted of non
steroidal anti-inﬂammatory drug (NSAID) was given to all pa-
tients scoring more than or equal 4 (Rescue analgesia) scored
according to visual analog scale (VAS; 0 = no pain and
10 = worst imaginable pain). Total consumption of analgesicsTable 1 The demographic characteristics of the three studied group
Value (mean ± SD) Group I (n= 30) Group
Age (year) 34.3 (±5.6) 34.4 (±
Height (cm) 166.5 (±5.5) 165.5
BMI 25.6 (±1.4) 26.2 (±
M/F (%) 17/13 (56.7%) 18/12
n, number of patients; M, male; F, female; BMI, body mass index. P>
Table 2 The intra-operative hemodynamic and oxygen saturation d
Variable (mean ± SD) Group I (n= 30) Grou
Systolic (mmHg) 112.8 (±10) 115 (
Diastolic (mmHg) 67.3 (±6.7) 72 (±
MAP (mm Hg) 89.3 (±6.8) 90 (±
Heart rate (beats/min) 68.7 (±3.2) 69.9
% of SpO2 97.97 (±1.1) 96.9
RR (breaths/min) 14.3 (±2.6) 13.9
n, number of patients; MAP, mean arterial blood pressure; RR, respirato
Table 3 Characteristics of sensory and motor block difference betw
Groups I (n= 30
Peak T8 (5–9)
Times to peak (min) 13.13 (±1.2)
Motor block at the peak 2.6 (±0.49)
Times to 2 segments regression from peak (min) 37.53 (±4.64)
Times to S2 regression (min) 160.13 (±9.34)
Motor block duration (min) 173.4 (±9.05)
PACU time (min) 113.63 (±6.62)
Values are expressed as mean ± SD except height of block expressed as m
number of patients. P> 0.05 non-signiﬁcant.in the ﬁrst 24 h (monitoring period) after spinal anesthesia was
also recorded (Fig. 1).
3.1. Statistical analysis
SPSS statistics (V. 19.0, IBM Corp., USA, 2010) was used for
data analysis. Data was expressed as mean ± SD for quantita-
tive parametric measures in addition to median percentiles for
quantitative non-parametric measures and both number and
percentage for categorized data. The following tests were used:
Analysis of Variance (ANOVA), the multiple comparisons
(post hoc test or least signiﬁcant difference, LSD) and Chi-
square test. The probability of error less than 0.05 was consid-
ered signiﬁcant, while at 0.01 and 0.001 are highly signiﬁcant.
4. Results
The study assessed the effect of intrathecal Bupivacain–Lido-
caine combination at different doses (6 and 12 mg) of Lido-
caine on the onset and recovery of anesthesia, times to retain
motor ability, analgesia time, postoperative analgesia required,
hemodynamic side effect and neurological complications espe-
cially transient neurological symptoms (TNS).s using ANOVA test except M/F % using Chi-square test.
II (n= 30) Group III (n= 30) P-value
2.9) 34.5 (±4) 0.989
(±5) 165.5 (±5) 0.702
1.3) 26.4 (±2.2) 0.168
(60%) 20/10 (66.7%) 0.72
0.05 non-signiﬁcant.
ifference in the three studied groups using ANOVA test.
p II (n= 30) Group III (n= 30) P-value
±10.3) 110.7(±7.4) 0.204
9.9) 69.7 (±6.6) 0.076
6.5) 92.5 (±2.4) 0.459
(±2.5) 68.6 (±2.6) 0.138
(±1.3) 98.4 (±1.04) 0.683
(±2.4) 14.2 (±2.2) 0.861
ry rate; SpO2, oxygen saturation rate. P> 0.05 non-signiﬁcant.
een the three groups using ANOVA test.
) Group II (n= 30) Group III (n= 30) P-value
T8 (5–10) T6 (4–8) <0.001
13.23 (±2.03) 11.87 (±3.08) 0.036
2.63 (±0.49) 2.63 (±0.49) 0.955
32.67 (±4.62) 42.8 (±3.72) <0.001
121.23 (±9.60) 199.53 (±11.71) <0.001
131.07 (±8.07) 216.5 (±7.77) <0.001
75.63 (±6.64) 164.17 (±8.96) <0.001
edian with range of max and min. PACU, post-anesthesia care unit; n,
64 S. El-Adawy et al.As shown in Table 1, there were no signiﬁcant differences in
the demographic data between the three studied groups.
Table 2 shows that there were no statistically signiﬁcant dif-
ferences between the three groups as regard intra-operative
hemodynamic with high degree of stability between three
groups.
As regard postoperative hemodynamic there were no statis-
tically signiﬁcant differences between the three groups. Table 3
summarizes the characteristics of sensory and motor block dif-
ference between the three groups. The median height of peak
sensory block in Group III was higher than in Groups I or
II (P< 0.01), While there was no signiﬁcant difference be-
tween Group I and II (P< 0.05). The onset times of sensory
block was shorter in Group III than Groups I or II, while there
was no signiﬁcant difference between Group I and II
(P< 0.05). The degrees of motor block at the time of peak
sensory block were statistically non different among the three
groups. The recovery proﬁle show high signiﬁcant difference
between the three groups detailed as following: the Times to
2 segments regression from peak, Times to S2 regression (sen-
sory block duration) and motor block duration was signiﬁ-
cantly shorter in Group II than Groups I than Group III in
order (P< 0.001). Also the PACU time was signiﬁcantly
shorter in Group II than Groups I than Group III in order
(P< 0.01). No patient required general anesthesia. No pa-
tients experienced postdural puncture headache, TNS or other
side effects after the surgery.5. Discussion
As regard intra-operative, postoperative hemodynamic and
oxygen saturation evaluation, no signiﬁcant difference between
the three studied groups was recorded. Stable hemodynamic
response with the intrathecal mini-dose Lidocaine added to
Bupivacaine may be due to the fact that a smaller dose of anes-
thetic allows for activation of homeostatic vasoconstrictive
compensatory mechanisms.6
The results of the present study agree with Nair et al.7 who
showed that no clinically relevant changes in blood pressure,
heart rate values, oxygen saturation and respiratory function
have been reported following the systematic review of
spinal anesthesia using Bupivacaine for ambulatory knee
arthroscopy.
Similarly, Bogra et al.8 performed a study on 120 cesarean
section parturient divided into six groups, identiﬁed as B8, B10
and B12.5 received 8, 10 and 12.5 mg of Bupivacaine mg alone
and FB8, FB10 and FB12.5 received a combination of 12.5 lg
intrathecal Fentanyl, respectively. The study concluded that
Bupivacaine–Fentanyl combination leads to abolishment of
the visceral pain, reduction in nausea incidence, increased
hemodynamic stability and increased the duration of post-
operative analgesia.
As regard characteristics of sensory and motor block, the
combination of intrathecal Lidocaine (12 mg) added to Bupiv-
acaine (7.5 mg) in Group III provide higher peak and faster on-
set of block this only statistically but clinically a mean 1 min
difference was not signiﬁcant. Regarding the recovery proﬁle,
Group II of Intrathecal Lidocaine (6 mg) added to Bupivacaine
(7.5 mg) produced more rapid recovery from the spinal block
compared to the same dose of Bupivacaine (7.5 mg) alone in
Group I and the larger dose of Lidocaine (12 mg) in GroupIII which had delayed the recovery, this shown in rapid retain
of the sensation (78 min mean difference), the motor ability
(85 min mean difference) and shorter PACU time (89 min mean
difference). The mechanism of the accelerated recovery is not
clear but the additional Lidocaine might have induced vasodi-
latation of spinal blood vessels and increasing the clearance of
Bupivacaine from the intrathecal space.5
This is in agreement with the results of Cle´ment et al., who
stated that larger doses of Lidocaine had prolonged the recov-
ery; perhaps the effect of Lidocaine on the recovery reﬂects a
balance between vasodilator effects at low doses and the direct
local anesthetic action at higher doses.3
Sheridh and Kelani, compared the different effects of a
combination of 2% Lignocaine plus Fentanyl and 0.5% heavy
Bupivacaine in patients underwent subarachnoid anesthesia
for transurethral surgery and concluded that intrathecal
Lignocaine 2% (2.5–3 mL) plus 25 lg Fentanyl provide a good
choice for this types of surgery with minimal side effect but
with higher failure rate due to the small dose of Lignocaine
and this is consistent with the failure of some cases in this
study especially those require longer duration.9
The factors that inﬂuence the height of spinal anesthetic
block include volume, concentration, baricity, site of injection
and patient position.2 The speciﬁc gravities of 1% and 2%
Lidocaine are almost equivalent to saline, minimizing the ef-
fects of baricity. Since the 0.6 mL of saline or Lidocaine was
mixed with 0.5% Bupivacaine in 8% dextrose solution, the
baracities of the spinal injectates were indistinguishable among
the groups.7
As regard the time TO the ﬁrst analgesic dose postopera-
tively (analgesia time), Group II of intrathecal Lidocaine
(6 mg) added to Bupivacaine (7.5 mg) decrease time to ﬁrst
analgesics administration with (75 min analgesic mean differ-
ence) but did not affect the total number of analgesic doses
(all groups received only one dose) within the monitoring per-
iod (24 h). On other hand the patient satisfaction was not eval-
uated. This agrees with Dobrydnjov et al. who founded that,
the use of clonidine as adjuvant to small-dose (6 mg) Bupiva-
caine is effective for ambulatory inguinal herniorrhaphy. The
addition of intrathecal clonidine 15 or 30 lg to small-dose
Bupivacaine increased the spread and duration of analgesia
and produced an effective spinal anesthesia.10
The absence of TNS or any permanent neurological defect
was reported in this study with no signiﬁcant difference be-
tween the three groups, this agree with Umbrain et al.11 who
investigated whether intrathecal Lidocaine administration is
accompanied with changes of cerebrospinal ﬂuid prostaglan-
din E2 (PGE2) levels (a microdialysis study in freely moving
rats). They observed that as the spinal PGE2 increases the
TNS increase, together with the observation that prolonged
duration of spinal PGE2 increased in the Lidocaine
1000 mcg group. This may imply that the observed PGE2
changes are dose-dependent. This has been linked the dose
to TNS. Our study together with this new theory supports
the reuse of small doses Lidocaine in these types of surgeries.
But, this disagree with the Systematic Review of Random-
ized, Controlled Trials of Transient Neurologic Symptoms
After Spinal Anesthesia with Lidocaine Versus Other Local
Anesthetics by Zaric et al.2, which compared the frequency
of TNS and neurologic complications after spinal anesthesia
with Lidocaine with the frequency of these adverse effects after
other local anesthetics in adult surgical patients using different
Effect of intrathecal Bupivacaine–Lidocaine combination 65concentrations and doses of Lidocaine that concluded that the
incidence of TNS was not dose dependent.
In spite of that, the incidence of the TNS has never been
examined with very small doses of spinal Lidocaine, as the
smallest dose examined was by Freedman et al.,12 where their
deﬁnition of ‘‘small-dose’’ Lidocaine was 50 mg or less. So, it
remains unknown if substantially smaller doses would reduce
the incidence of TNS or not.
David et al., investigated the incidence of TNS after spinal
Lidocaine in a dose range below that examined by Freedman
et al., by including 110 adult ASA physical status I and II pa-
tients presenting for arthroscopic surgery of the knee. They
were randomly assigned to one of two groups as follows:
Group L50 received 1% hypobaric Lidocaine 50 mg and
Group L20/F25 received 20 mg of 1% hypobaric Lidocaine +
25 lg Fentanyl (ﬁnal concentration of Lidocaine was 0.8%).
They concluded on the basis of the follow-up interview that
TNS was 32.7% of the Group L50 patients as opposed to
3.6% of the Group L20/F25 patients (P< 0.0001) which sup-
port the theory that smaller doses investigation reveals the ef-
fect of the dose on the incidence of TNS.13
6. Conclusion
This study has shown that the median height of peak sensory
block in Group III was higher than in Groups I or II
(P< 0.01), While there was no signiﬁcant difference between
Group I and II (P< 0.05). The onset times of sensory block
was shorter in Group III than Groups I or II, while there
was no signiﬁcant difference between Group I and II
(P< 0.05). The degrees of motor block at the time of peak
sensory block were statistically non different among the three
groups. The recovery proﬁle show high signiﬁcant difference
between the three groups detailed as following the Times to
2 segments regression from peak, Times to S2 regression (sen-
sory block duration) and motor block duration were signiﬁ-
cantly shorter in Group II than Groups I than Group III in
order (P< 0.001). Also the PACU time was signiﬁcantly
shorter in Group II than Groups I than Group III in order
(P< 0.01) .This is in addition to stable hemodynamic together
with the absence of transient neurological symptoms.7. Recommendation
These results recommended that the use of intrathecal (0.6 mL
of 1% Lidocaine mixed with 1.5 mL of 0.5% hyperbaric
Bupivacaine) is an excellent alternative to heavy Bupivacaine
alone for ambulatory surgery as it can shorten the duration
of Bupivacaine spinal block, therefore providing more rapid
recovery, stable hemodynamic together with absence of tran-
sient neurological symptoms, so that overcoming both heavy
Bupivacaine drawbacks which are hemodynamic instability
and prolonged motor block and the Lidocaine one which is
TNS. On the other hand this mixture may not be effectivefor ambulatory inguinal herniorrhaphy with these doses but
the small number form a barrier to provide precise result. An-
other drawback of this mixture is that it had decreased the time
to ﬁrst postoperative analgesics administration but this is to-
gether with the fact that it did not affect the total number of
analgesic doses (all groups received only one dose) within the
monitoring period (24 h) but on other hand the patient satis-
faction was needed to be evaluated. As regard difference in
the time of the stay in hospital between groups, it could not
be concluded as all patients discharged in the second day
morning. Further studies in different doses in these parts are
required.
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